v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Class A Common Stock
Common Stock
Class V Common Stock
Accumulated Deficit
Accumulated Other Comprehensive Loss
Treasury Stock
Total Stockholders' Deficit Attributable to biote Corp.
Non-Controlling Interest
Beginning balance at Dec. 31, 2024 $ (102,200) $ 3 $ 1 $ (100,297) $ (35) $ (5,600) $ (105,928) $ 3,728
Beginning balance, shares at Dec. 31, 2024   31,485,777 5,221,653          
Distributions (694)             (694)
Net income 15,839     13,718     13,718 2,121
Other comprehensive income (loss) (4)       (4)   (4)  
Share-based compensation 2,127     2,127     2,127  
TRA liability 106     106     106  
Ending balance at Mar. 31, 2025 (84,826) $ 3 $ 1 (84,346) (39) (5,600) (89,981) 5,155
Ending balance, shares at Mar. 31, 2025   31,485,777 5,221,653          
Beginning balance at Dec. 31, 2024 (102,200) $ 3 $ 1 (100,297) (35) (5,600) (105,928) 3,728
Beginning balance, shares at Dec. 31, 2024   31,485,777 5,221,653          
Ending balance at Dec. 31, 2025 (50,397) $ 3 $ 1 (49,549) (29) (8,965) (58,539) 8,142
Ending balance, shares at Dec. 31, 2025   30,713,367 5,221,653          
Distributions (405)             (405)
Net income 2,676     2,277     2,277 399
Other comprehensive income (loss) 2       2   2  
Share-based compensation 1,758     1,758     1,758  
Common stock repurchased (1,071)         (1,071) (1,071)  
Common stock repurchased, shares   (726,388)            
TRA liability (518)     (518)     (518)  
Ending balance at Mar. 31, 2026 $ (47,955) $ 3 $ 1 $ (46,032) $ (27) $ (10,036) $ (56,091) $ 8,136
Ending balance, shares at Mar. 31, 2026   29,986,979 5,221,653